scholarly journals Evaluation of a brief cognitive screening tool in primary care setting

2015 ◽  
Vol 357 ◽  
pp. e129
Author(s):  
D. Jiménez ◽  
M. Lavados ◽  
P. Rojas ◽  
C. Henriquez ◽  
M. Guillon ◽  
...  
2018 ◽  
Vol 101 (1) ◽  
pp. 98-105
Author(s):  
Javier Romero Otero ◽  
Borja García Gómez ◽  
José Medina Polo ◽  
Esther García Rojo ◽  
Eduardo García Cruz ◽  
...  

2017 ◽  
Vol 75 (7) ◽  
pp. 446-450 ◽  
Author(s):  
Ana Carolina Musser Tavares de Mattos ◽  
Jano Alves de Souza ◽  
Pedro Ferreira Moreira Filho ◽  
Mauro Eduardo Jurno ◽  
Luis Guilhermo Coca Velarde

ABSTRACT Objective To analyze the applicability of the Portuguese version of ID-MigraineTM in a sample of Brazilian patients. Methods Patients with headache were recruited from the neurology outpatient clinic of a tertiary hospital and submitted to the ID-MigraineTM questionnaire. The diagnosis of headache was made according to the ICHD-2 criteria. Results Of the 232 patients, 86% had migraine. The questionnaire showed a sensitivity of 92% (95%CI, 88% to 95%), specificity of 60% (95%CI, 43% to 77%) and a positive predictive value of 93% (95%CI, 89% to 96%). Discussion Our results were similar to other international studies of the ID-MigraineTM application. The Portuguese version is considered easy to use, and an appropriate screening tool for migraine diagnosis in our sample. Conclusion Considering the characteristics of our health system, we can infer that this questionnaire would be beneficial in a Brazilian primary care setting; however, more studies are necessary.


2021 ◽  
Vol 79 (7) ◽  
pp. 565-570
Author(s):  
Sérgio Ferreira de Ferreira-Filho ◽  
Wyllians Vendramini Borelli ◽  
Rodrigo Mantovani Sguario ◽  
Gustavo Fiorentin Biscaia ◽  
Vitória Schneider Müller ◽  
...  

ABSTRACT Background: Cognitive decline is a common condition, but is still underrepresented in studies conducted in developing countries. Objective: To calculate the prevalence of cognitive decline and depression in an elderly community-dwelling population in a city in southern Brazil. Methods: We calculated the prevalences of dementia, cognitive impairment with no dementia (CIND) and symptoms of depression in an elderly population relying on the public healthcare system. This epidemiological study in Pelotas, Brazil, was conducted within the primary care setting. It included 299 older adults (mean age = 69.75 ± 7.6 years) who presented low levels of education (mean = 4.16 ± 3.17 years of education). They underwent cognitive screening and their medical records were analyzed. Results: Among these older adults, 142 (47.5%) presented cognitive decline: 104 (34.8%) matching the cognitive criteria for CIND and 38 (12.7%) matching the cognitive criteria for dementia. Among all the individuals who completed the cognitive screening, 141 (48.4%) were positive for symptoms of depression, of whom 99 (34%) did not have any previous diagnosis in their medical records. Conclusion: There was high prevalence of cognitive impairment among these older adults in a primary care setting. A large number of older adults were found to have symptoms of depression without any diagnosis.


Author(s):  
M.N. Sabbagh ◽  
M. Boada ◽  
S. Borson ◽  
M. Chilukuri ◽  
B. Dubois ◽  
...  

Mild cognitive impairment (MCI) is significantly misdiagnosed in the primary care setting due to multi-dimensional frictions and barriers associated with evaluating individuals’ cognitive performance. To move toward large-scale cognitive screening, a global panel of clinicians and cognitive neuroscientists convened to elaborate on current challenges that hamper widespread cognitive performance assessment. This report summarizes a conceptual framework and provides guidance to clinical researchers and test developers and suppliers to inform ongoing refinement of cognitive evaluation. This perspective builds upon a previous article in this series, which outlined the rationale for and potentially against efforts to promote widespread detection of MCI. This working group acknowledges that cognitive screening by default is not recommended and proposes large-scale evaluation of individuals with a concern or interest in their cognitive performance. Such a strategy can increase the likelihood to timely and effective identification and management of MCI. The rising global incidence of AD demands innovation that will help alleviate the burden to healthcare systems when coupled with the potentially near-term approval of disease-modifying therapies. Additionally, we argue that adequate infrastructure, equipment, and resources urgently should be integrated in the primary care setting to optimize the patient journey and accommodate widespread cognitive evaluation.


2011 ◽  
Vol 20 (2) ◽  
pp. 184-189 ◽  
Author(s):  
Lazaros Sichletidis ◽  
Dionisios Spyratos ◽  
Maria Papaioannou ◽  
Diamantis Chloros ◽  
Anastasios Tsiotsios ◽  
...  

Diabetes Care ◽  
2020 ◽  
Vol 43 (10) ◽  
pp. e147-e148
Author(s):  
Alauddin Bhuiyan ◽  
Arun Govindaiah ◽  
Avnish Deobhakta ◽  
Meenakashi Gupta ◽  
Richard Rosen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document